Sektor Samsung Biologics Co.,Ltd.

Aktien

A207940

KR7207940008

A207940

Pharmazeutika

Schlusskurs Korea S.E. 13.02.2026 % 5 Tage Veränd. 1. Jan.
1’710’000.00 KRW -0.52% Intraday Chart für Samsung Biologics Co.,Ltd. +71.00% +71.00%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
-0.52%+71.00%+71.00%+71.00%+71.00%+71.00%+71.00%+71.00% - 54.78 Mrd.
-0.17%+4.93%+8.07%+12.47%+2.63%+17.60%+5.80%+64.46%+99.41% 81.43 Mrd.
+0.67%+7.70%+7.45%+24.85%+19.61%+56.60%+266.37%+230.25%+274.54% 63.71 Mrd.
-0.07%-6.58%-13.49%-15.21%-11.56%-42.12%-48.83%-47.17%+51.67% 51.59 Mrd.
-0.76%+2.72%+18.07%+17.88%+10.31%+41.36%-30.26%-29.83%-26.92% 28.71 Mrd.
+1.81%+2.94%-3.03%-1.13%+4.27%+46.25%+30.37%+22.94%+38.33% 20.13 Mrd.
+0.56%-0.61%-0.45%-1.87%+16.85%+131.43%+124.43%-10.36% - 19.78 Mrd.
+6.08%+10.97%+11.40%+88.21%+58.02%+41.25%-72.03%-73.64% - 17.16 Mrd.
+2.48%+5.30%+26.96%+25.00%+26.50%+33.23%+77.71%+155.38%+285.88% 15.76 Mrd.
-2.53%+2.01%-3.06%+10.51%-3.35%+111.83%+464.35%+14.23% - 14.62 Mrd.
-2.05%+1.06%-26.25%-30.29%-15.02%-4.14%+858.59%+386.62%+8’917.70% 14.14 Mrd.
+3.14%+3.64%+13.26%+13.53%+4.04%-4.66%-42.91%-27.94%-20.54% 11.52 Mrd.
-0.04%-0.08%+0.44%+3.04%+0.97%+125.41%+183.94%+225.28% - 10.98 Mrd.
+0.79%+0.24%+4.21%+26.92%+1.15%+40.86%+177.30%+156.51%+2’150.18% 9.24 Mrd.
-1.58%+4.65%-0.61%+36.03%+14.91%+84.87%+262.03%+276.27% - 8.35 Mrd.
+0.75%+0.93%+4.18%+7.18%+6.03%+20.00%-20.55%-49.91%-40.74% 8.09 Mrd.
+0.94%-3.59%-10.80%-28.64%-2.32%+264.51%+181.86%+180.52%+158.71% 7.55 Mrd.
-0.77%-3.23%-10.91%-27.09%-10.64%-41.97%-55.73%-66.19% - 7.35 Mrd.
-0.64%-1.58%-0.95%-8.50%-1.58%-11.49%+1.30%-20.61%-71.44% 5.97 Mrd.
-1.00%-2.99%-10.68%-20.43%-10.44%-36.20%-72.18%-88.08%+91.90% 5.86 Mrd.
Durchschnitt +0.13%+0.53%+4.24%+10.17%+9.07%+47.28%+118.13%+68.49%+916.05% 22.84 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung +0.12%+1.17%+10.89%+17.52%+14.67%+39.98%+99.99%+73.07%+554.40%
Biopharmazeutika
  1. Börse
  2. Aktien
  3. A207940 Aktie
  4. Sektor Samsung Biologics Co.,Ltd.